ID

37368

Descrizione

Study ID: 111592 Clinical Study ID: 111592 Study Title: A Randomized, Double-blind, Placebo-controlled, Doseescalation Study to Assess the Anti-inflammatory Activity, Efficacy, and Safety of Intravenous SB-681323 in Subjects at Risk for Development of Acute Lung Injury or ARDS Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996840 See https://clinicaltrials.gov/ct2/show/NCT00996840 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Placebo, SB-681323 Trade Name: N/A Study Indication: Lung Injury, Acute The primary objective of this phase 2 trial is to evaluate the safety and tolerability of intravenous dilmapimod/SB-681323 given in escalating dosages and over different intervals for three days in trauma patients at risk for the development of ALI or ARDS. This study consists of Screening, infusion of dilmapimod/SB-681323 on days 1-3, examination/sampling up to early day 5 (denoted as "Day 3 - 48 hrs") and a Follow-up on day 7. There are four cohorts, cohorts 1 and 3 receive the medication (or placebo) infusion over 4 hours, cohorts 2 and 4 over 24 hours. This form contains data on the participant's initial trauma, and is to be filled in at Screening.

collegamento

https://clinicaltrials.gov/ct2/show/NCT00996840

Keywords

  1. 20/07/19 20/07/19 -
Titolare del copyright

GlaxoSmithKline

Caricato su

20 luglio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

SB-681323 in ALI/ARDS risk patients - NCT00996840

  1. StudyEvent: ODM
    1. Trauma
Administrative Data
Descrizione

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Number
Descrizione

Subject Number

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
Date/Time of Assessment
Descrizione

Date/Time of Assessment

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C1516048
UMLS CUI [1,2]
C1264639
Trauma
Descrizione

Trauma

Alias
UMLS CUI-1
C3714660
Date and approx. time of Trauma
Descrizione

Date/Time of Trauma

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C3263723
UMLS CUI [1,2]
C1264639
Date/time of Hospitalisation
Descrizione

Date/time of Hospitalisation

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C1264639
Glasgow Coma Scale
Descrizione

Glasgow Coma Scale

Alias
UMLS CUI-1
C1271007
Glasgow Coma Scale (total score)
Descrizione

Glasgow Coma Scale

Tipo di dati

integer

Alias
UMLS CUI [1]
C1271007
Injury Severity Score
Descrizione

Injury Severity Score

Alias
UMLS CUI-1
C0021504
Injury Severity Score (total score)
Descrizione

Injury Severity Score

Tipo di dati

integer

Alias
UMLS CUI [1]
C0021504

Similar models

Trauma

  1. StudyEvent: ODM
    1. Trauma
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject Number
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Date/Time of Assessment
Item
Date/Time of Assessment
datetime
C1516048 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Item Group
Trauma
C3714660 (UMLS CUI-1)
Date/Time of Trauma
Item
Date and approx. time of Trauma
datetime
C3263723 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Date/time of Hospitalisation
Item
Date/time of Hospitalisation
datetime
C0019993 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Item Group
Glasgow Coma Scale
C1271007 (UMLS CUI-1)
Glasgow Coma Scale
Item
Glasgow Coma Scale (total score)
integer
C1271007 (UMLS CUI [1])
Item Group
Injury Severity Score
C0021504 (UMLS CUI-1)
Injury Severity Score
Item
Injury Severity Score (total score)
integer
C0021504 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial